<PAGE>
EXHIBIT 99.1
Contact:
---------
Mark R. Vincent
---------------
Director, Corporate Communications
& Investor Relations
[email protected]
CuraGen Corporation
1-888-GENOMICS
www.curagen.com
---------------
FOR IMMEDIATE RELEASE
---------------------
CURAGEN CORPORATION PRICES PUBLIC OFFERING OF 4,800,000
SHARES OF COMMON STOCK
NEW HAVEN, CT -- NOVEMBER 16, 2000 -- CuraGen Corporation, AN INTEGRATED
GENOMICS BASED DRUG DISCOVERY AND DEVELOPMENT COMPANY (NASDAQ: CRGN), announced
today that it priced its public offering of 4,800,000 newly issued shares of
common stock at $41.00 per share. The net proceeds to CuraGen are expected to be
approximately $186.5 million.
The offering was jointly lead-managed by Morgan Stanley Dean Witter and Lehman
Brothers, and co-managed by Dain Rauscher Wessels; Bear, Stearns & Co. Inc.;
Prudential Vector Healthcare, a unit of Prudential Securities; and Thomas Weisel
Partners LLC. CuraGen has granted the underwriters an option to purchase up to
720,000 additional shares to cover any over-allotments.
A copy of the final prospectus related to the offering can be obtained from
Morgan Stanley Dean Witter at 1585 Broadway, New York, NY 10036, (212) 761-4000.
CuraGen Corporation is advancing the discovery and development of pharmaceutical
and life science products through the systematic application of genomics.
CuraGen's fully integrated, Internet-based functional genomic technologies,
services, and information systems are designed to rapidly generate comprehensive
information about genes, human genetic variations, gene expression, protein
expression, protein pathways, and potential drugs that affect these pathways.
The Company is applying this comprehensive functional genomic platform to
develop protein and antibody drugs, and to identify small molecule drug targets.
CuraGen has conducted research for collaborators including Abgenix, Biogen, COR
Therapeutics, Dupont/Pioneer Hi-Bred International, Gemini Genomics, Genentech,
Glaxo Wellcome, Hoffmann-La Roche, Ono Pharmaceuticals, and Roche Vitamins.
CuraGen employs over 300 people and is headquartered in New Haven, CT.
32
